Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01695993 · ClinicalTrials.gov registry record · NA
Alternative Approaches for Nausea Control
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT01695993: Completed NA study, sponsored by University of Rochester.
NCT01695993 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 242 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01695993, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
216 Chemotherapy-naïve, female breast cancer patients about to begin chemotherapy and who expect to have nausea, will be entered. Participants will be randomized to one of three study arms: Arm 1: control; Arm 2: Expectancy-neutral handout + Expectancy-neutral MP3+ acupressure bands; Arm 3: Expectancy-enhancing handout + Expectancy-enhancing MP3 + acupressure bands. Hypothesis: Acupressure bands provided with the relaxation MP3 will be effective in controlling chemotherapy-induced nausea
Primary Outcome
Nausea and will be measured by a patient report diary completed by patients over a five-day period. Each day is divided into four segments (morning, afternoon, evening, night) in which patients report the severity of nausea and number of vomiting episodes for each period of the day. Severity of nausea is assessed on a 7-point rating scale, anchored at one end by 1 = "Not at all nauseated" and at the other end by 7 = "Extremely nauseated." The outcome variable for the primary analysis was greates
Interventions
- DEVICE Acupressure bands
- OTHER Expectancy-neutral handout
- BEHAVIORAL Expectancy-neutral MP3
- OTHER Expectancy-enhancing handout
- BEHAVIORAL Expectancy-enhancing MP3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-05-16 |
| Phase | NA |
What the finished NCT01695993 record still lists
NCT01695993 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 5 interventions - of which Acupressure bands is the first listed.
NCT01695993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01695993 about?
NCT01695993 is a clinical study titled "Alternative Approaches for Nausea Control". 216 Chemotherapy-naïve, female breast cancer patients about to begin chemotherapy and who expect to have nausea, will be entered. Participants will be randomized to one of three study arms: Arm 1: control; Arm 2: Expectancy-neutral handout + Expectancy-neutral MP3+ acupressure bands; Arm 3: Expectan...
What is the current status of trial NCT01695993?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2012-11. Estimated completion is 2017-05-16.
What interventions are being tested in trial NCT01695993?
The interventions under investigation include: Acupressure bands (DEVICE), Expectancy-neutral handout (OTHER), Expectancy-neutral MP3 (BEHAVIORAL), Expectancy-enhancing handout (OTHER), Expectancy-enhancing MP3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT01695993?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01695993's enrollment target sits among peer trials
242 439th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia